메뉴 건너뛰기




Volumn 7, Issue , 2009, Pages

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOLTERODINE; BENZHYDRYL DERIVATIVE; CRESOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE;

EID: 62149152079     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-13     Document Type: Article
Times cited : (24)

References (33)
  • 2
    • 0037253578 scopus 로고    scopus 로고
    • The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society
    • 10.1016/S0090-4295(02)02243-4 12559262
    • Abrams P Cardozo L Fall M Griffiths D Rosier P Ulmsten U Van Kerrebroeck P Victor A Wein A The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society Urology 2003, 61(1):37-49. 10.1016/ S0090-4295(02)02243-4 12559262
    • (2003) Urology , vol.61 , Issue.1 , pp. 37-49
    • Abrams, P.1    Cardozo, L.2    Fall, M.3    Griffiths, D.4    Rosier, P.5    Ulmsten, U.6    Van Kerrebroeck, P.7    Victor, A.8    Wein, A.9
  • 4
    • 0035725404 scopus 로고    scopus 로고
    • How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study
    • 10.1046/j.1464-410x.2001.02228.x 11412210
    • Milsom I Abrams P Cardozo L Roberts RG Thuroff J Wein AJ How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 2001, 87(9):760-766. 10.1046/ j.1464-410x.2001.02228.x 11412210
    • (2001) BJU Int , vol.87 , Issue.9 , pp. 760-766
    • Milsom, I.1    Abrams, P.2    Cardozo, L.3    Roberts, R.G.4    Thuroff, J.5    Wein, A.J.6
  • 5
    • 33750617633 scopus 로고    scopus 로고
    • Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study
    • 10.1016/j.eururo.2006.09.019 17049716
    • Irwin DE Milsom I Hunskaar S Reilly K Kopp Z Herschorn S Coyne KS Kelleher C Hampel C Artibani W et al Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study Eur Urol 2006, 50:1306-1315. 10.1016/j.eururo.2006.09.019 17049716
    • (2006) Eur Urol , vol.50 , pp. 1306-1315
    • Irwin, D.E.1    Milsom, I.2    Hunskaar, S.3    Reilly, K.4    Kopp, Z.5    Herschorn, S.6    Coyne, K.S.7    Kelleher, C.8    Hampel, C.9    Artibani, W.10
  • 6
    • 0346250806 scopus 로고    scopus 로고
    • Antimuscarinics for the treatment of overactive bladder
    • 10.1016/S1474-4422(03)00622-7 14693111
    • Andersson KE Antimuscarinics for the treatment of overactive bladder Lancet Neurol 2004, 3(1):46-53. 10.1016/S1474-4422(03)00622-7 14693111
    • (2004) Lancet Neurol , vol.3 , Issue.1 , pp. 46-53
    • Andersson, K.E.1
  • 7
    • 0000078123 scopus 로고    scopus 로고
    • Recommendations for evaluating the validity of quality of life claims for labeling and promotion
    • 10.1046/j.1524-4733.1999.02210.x 16674343
    • Leidy NK Revicki DA Geneste B Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value Health 1999, 2:113-127. 10.1046/j.1524-4733.1999.02210.x 16674343
    • (1999) Value Health , vol.2 , pp. 113-127
    • Leidy, N.K.1    Revicki, D.A.2    Geneste, B.3
  • 8
    • 0038626769 scopus 로고    scopus 로고
    • Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder
    • 10.1023/A:1023422208910 12797715
    • Reese PR Pleil AM Okano GJ Kelleher CJ Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder Qual Life Res 2003, 12(4):427-442. 10.1023/ A:1023422208910 12797715
    • (2003) Qual Life Res , vol.12 , Issue.4 , pp. 427-442
    • Reese, P.R.1    Pleil, A.M.2    Okano, G.J.3    Kelleher, C.J.4
  • 9
    • 33646374418 scopus 로고    scopus 로고
    • The validation of the patient perception of bladder condition (PPBC): A single-item global measure for patients with overactive bladder
    • 10.1016/j.eururo.2006.01.007 16460875
    • Coyne KS Matza LS Kopp Z Abrams P The validation of the patient perception of bladder condition (PPBC): A single-item global measure for patients with overactive bladder Eur Urol 2006, 49(6):1079-1086. 10.1016/ j.eururo.2006.01.007 16460875
    • (2006) Eur Urol , vol.49 , Issue.6 , pp. 1079-1086
    • Coyne, K.S.1    Matza, L.S.2    Kopp, Z.3    Abrams, P.4
  • 10
    • 0036347475 scopus 로고    scopus 로고
    • Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q
    • 10.1023/A:1016370925601 12206577
    • Coyne K Revicki D Hunt T Corey R Stewart W Bentkover J Kurth H Abrams P Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q Qual Life Res 2002, 11(6):563-574. 10.1023/A:1016370925601 12206577
    • (2002) Qual Life Res , vol.11 , Issue.6 , pp. 563-574
    • Coyne, K.1    Revicki, D.2    Hunt, T.3    Corey, R.4    Stewart, W.5    Bentkover, J.6    Kurth, H.7    Abrams, P.8
  • 11
    • 0035019377 scopus 로고    scopus 로고
    • Health-related quality of life among adults with symptoms of overactive bladder: Results from a U.S. community-based survey
    • 10.1016/S0090-4295(01)00986-4 11377301
    • Liberman JN Hunt TL Stewart WF Wein A Zhou Z Herzog AR Lipton RB Diokno AC Health-related quality of life among adults with symptoms of overactive bladder: Results from a U.S. community-based survey Urology 2001, 57(6):1044-1050. 10.1016/S0090-4295(01)00986-4 11377301
    • (2001) Urology , vol.57 , Issue.6 , pp. 1044-1050
    • Liberman, J.N.1    Hunt, T.L.2    Stewart, W.F.3    Wein, A.4    Zhou, Z.5    Herzog, A.R.6    Lipton, R.B.7    Diokno, A.C.8
  • 12
    • 3843056689 scopus 로고    scopus 로고
    • The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: Results from a national community survey
    • 10.1111/j.1524-4733.2004.74008.x 15449637
    • Coyne KS Payne C Bhattacharyya SK Revicki DA Thompson C Corey R Hunt TL The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: Results from a national community survey Value Health 2004, 7(4):455-463. 10.1111/j.1524-4733.2004.74008.x 15449637
    • (2004) Value Health , vol.7 , Issue.4 , pp. 455-463
    • Coyne, K.S.1    Payne, C.2    Bhattacharyya, S.K.3    Revicki, D.A.4    Thompson, C.5    Corey, R.6    Hunt, T.L.7
  • 13
    • 0345257967 scopus 로고    scopus 로고
    • The impact on health-related quality of life of stress, urge and mixed urinary incontinence
    • 10.1046/j.1464-410X.2003.04463.x 14616456
    • Coyne KS Zhou Z Thompson C Versi E The impact on health-related quality of life of stress, urge and mixed urinary incontinence BJU Int 2003, 92(7):731-735. 10.1046/j.1464-410X.2003.04463.x 14616456
    • (2003) BJU Int , vol.92 , Issue.7 , pp. 731-735
    • Coyne, K.S.1    Zhou, Z.2    Thompson, C.3    Versi, E.4
  • 14
    • 0033849075 scopus 로고    scopus 로고
    • Overactive bladder significantly affects quality of life
    • 11183901
    • Abrams P Kelleher C Lerr L Rogers R Overactive bladder significantly affects quality of life Am J Manag Care 2000, 6:S580-590. 11183901
    • (2000) Am J Manag Care , vol.6
    • Abrams, P.1    Kelleher, C.2    Lerr, L.3    Rogers, R.4
  • 15
    • 33644807986 scopus 로고    scopus 로고
    • Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries
    • 10.1111/j.1464-410X.2005.05889.x 16336336
    • Irwin DE Milsom I Kopp Z Abrams P Cardozo L Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries BJU Int 2006, 97(1):96-100. 10.1111/ j.1464-410X.2005.05889.x 16336336
    • (2006) BJU Int , vol.97 , Issue.1 , pp. 96-100
    • Irwin, D.E.1    Milsom, I.2    Kopp, Z.3    Abrams, P.4    Cardozo, L.5
  • 16
    • 0036925567 scopus 로고    scopus 로고
    • Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder
    • 12516955
    • Kelleher CJ Reese PR Pleil AM Okano GJ Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder Am J Manag Care 2002, 8 (19 Suppl):S608-S615. 12516955
    • (2002) Am J Manag Care , vol.8 , Issue.19 SUPPL.
    • Kelleher, C.J.1    Reese, P.R.2    Pleil, A.M.3    Okano, G.J.4
  • 17
    • 21644437439 scopus 로고    scopus 로고
    • Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: A randomized, placebo-controlled trial
    • 10.1007/s00345-004-0455-3 15455256
    • Homma Y Kawabe K Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: A randomized, placebo-controlled trial World J Urol 2004, 22(4):251-256. 10.1007/s00345-004-0455-3 15455256
    • (2004) World J Urol , vol.22 , Issue.4 , pp. 251-256
    • Homma, Y.1    Kawabe, K.2
  • 18
    • 0141921336 scopus 로고    scopus 로고
    • Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine
    • 10.1016/S0029-7844(03)00623-9 12962951
    • Freeman R Hill S Millard R Slack M Sutherst J Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine Obstet Gynecol 2003, 102(3):605-611. 10.1016/ S0029-7844(03)00623-9 12962951
    • (2003) Obstet Gynecol , vol.102 , Issue.3 , pp. 605-611
    • Freeman, R.1    Hill, S.2    Millard, R.3    Slack, M.4    Sutherst, J.5
  • 19
    • 33744540100 scopus 로고    scopus 로고
    • Tolterodine extended release improves patient-reported outcomes in overactive bladder: Results from the IMPACT trial
    • 10.1111/j.1742-1241.2006.00987.x 16805764
    • Roberts R Bavendam T Glasser DB Carlsson M Eyland N Elinoff V Tolterodine extended release improves patient-reported outcomes in overactive bladder: Results from the IMPACT trial Int J Clin Pract 2006, 60:752-758. 10.1111/j.1742-1241.2006.00987.x 16805764
    • (2006) Int J Clin Pract , vol.60 , pp. 752-758
    • Roberts, R.1    Bavendam, T.2    Glasser, D.B.3    Carlsson, M.4    Eyland, N.5    Elinoff, V.6
  • 20
    • 33746883214 scopus 로고    scopus 로고
    • Assessment of treatment outcomes in patients with overactive bladder: Importance of objective and subjective measures
    • 10.1016/j.urology.2006.05.044
    • Abrams P Artibani W Gajewski JB Hussain I Assessment of treatment outcomes in patients with overactive bladder: Importance of objective and subjective measures Urology 2006, 68(suppl 2A):17-28. 10.1016/ j.urology.2006.05.044
    • (2006) Urology , vol.68 , Issue.SUPPL. 2A , pp. 17-28
    • Abrams, P.1    Artibani, W.2    Gajewski, J.B.3    Hussain, I.4
  • 21
    • 0035126767 scopus 로고    scopus 로고
    • Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder
    • 10.1016/S0090-4295(00)01113-4 11248608
    • van Kerrebroeck P Kreder K Jonas U Zinner N Wein A Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder Urology 2001, 57(3):414-421. 10.1016/ S0090-4295(00)01113-4 11248608
    • (2001) Urology , vol.57 , Issue.3 , pp. 414-421
    • van Kerrebroeck, P.1    Kreder, K.2    Jonas, U.3    Zinner, N.4    Wein, A.5
  • 22
    • 0030667817 scopus 로고    scopus 로고
    • A new questionnaire to assess the quality of life of urinary incontinent women
    • 9422015
    • Kelleher CJ Cardozo LD Khullar V Salvatore S A new questionnaire to assess the quality of life of urinary incontinent women Br J Obstet Gynaecol 1997, 104(12):1374-1379. 9422015
    • (1997) Br J Obstet Gynaecol , vol.104 , Issue.12 , pp. 1374-1379
    • Kelleher, C.J.1    Cardozo, L.D.2    Khullar, V.3    Salvatore, S.4
  • 23
    • 2942522429 scopus 로고    scopus 로고
    • How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder
    • 15198790 10.1111/j.1471-0528.2004.00129.x
    • Kelleher CJ Pleil AM Reese PR Burgess SM Brodish PH How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder BJOG 2004, 111(6):605-612. 15198790 10.1111/ j.1471-0528.2004.00129.x
    • (2004) BJOG , vol.111 , Issue.6 , pp. 605-612
    • Kelleher, C.J.1    Pleil, A.M.2    Reese, P.R.3    Burgess, S.M.4    Brodish, P.H.5
  • 24
    • 18144404636 scopus 로고    scopus 로고
    • Test-retest reliability of four questionnaires for patients with overactive bladder: The Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and the Primary OAB Symptom Questionnaire (POSQ)
    • 10.1002/nau.20110 15747340
    • Matza LS Thompson CL Krasnow J Brewster-Jordan J Zycyzynski T Coyne KS Test-retest reliability of four questionnaires for patients with overactive bladder: The Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and the Primary OAB Symptom Questionnaire (POSQ) Neurourol Urodyn 2005, 24:215-225. 10.1002/nau.20110 15747340
    • (2005) Neurourol Urodyn , vol.24 , pp. 215-225
    • Matza, L.S.1    Thompson, C.L.2    Krasnow, J.3    Brewster-Jordan, J.4    Zycyzynski, T.5    Coyne, K.S.6
  • 26
    • 0344395127 scopus 로고    scopus 로고
    • Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: A randomized, placebo-controlled trial
    • 10.1046/j.1464-410X.2003.04468.x 14616458
    • Homma Y Paick JS Lee JG Kawabe K Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: A randomized, placebo-controlled trial BJU Int 2003, 92(7):741-747. 10.1046/ j.1464-410X.2003.04468.x 14616458
    • (2003) BJU Int , vol.92 , pp. 741-747
    • Homma, Y.1    Paick, J.S.2    Lee, J.G.3    Kawabe, K.4
  • 27
    • 20644452883 scopus 로고    scopus 로고
    • Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder
    • 10.1016/j.eururo.2004.11.012 15967259
    • Michel MC de la Rosette JJ Piro M Schneider T Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder Eur Urol 2005, 48(1):110-115. 10.1016/ j.eururo.2004.11.012 15967259
    • (2005) Eur Urol , vol.48 , Issue.1 , pp. 110-115
    • Michel, M.C.1    de la Rosette, J.J.2    Piro, M.3    Schneider, T.4
  • 28
    • 43749116211 scopus 로고    scopus 로고
    • Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine
    • 10.1111/j.1742-1241.2008.01778.x 18479285
    • Coyne KS Elinoff V Gordon DA Deng DY Brodsky M Glasser DB Jumadilova Z Carlsson M Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine Int J Clin Pract 2008, 62(6):925-931. 10.1111/ j.1742-1241.2008.01778.x 18479285
    • (2008) Int J Clin Pract , vol.62 , Issue.6 , pp. 925-931
    • Coyne, K.S.1    Elinoff, V.2    Gordon, D.A.3    Deng, D.Y.4    Brodsky, M.5    Glasser, D.B.6    Jumadilova, Z.7    Carlsson, M.8
  • 29
    • 17744391866 scopus 로고    scopus 로고
    • The responsiveness of the Overactive Bladder Questionnaire (OAB-q)
    • 10.1007/s11136-004-0706-1 16022077
    • Coyne KS Matza LS Thompson CL The responsiveness of the Overactive Bladder Questionnaire (OAB-q) Qual Life Res 2005, 14:849-855. 10.1007/ s11136-004-0706-1 16022077
    • (2005) Qual Life Res , vol.14 , pp. 849-855
    • Coyne, K.S.1    Matza, L.S.2    Thompson, C.L.3
  • 30
    • 33746921274 scopus 로고    scopus 로고
    • Development and validation of patient-reported outcomes measures for overactive bladder
    • 10.1016/j.urology.2006.05.042
    • Coyne K Tubaro A Brubaker L Bavendam T Development and validation of patient-reported outcomes measures for overactive bladder Urology 2006, 68(suppl 2A):9-16. 10.1016/j.urology.2006.05.042
    • (2006) Urology , vol.68 , Issue.SUPPL. 2A , pp. 9-16
    • Coyne, K.1    Tubaro, A.2    Brubaker, L.3    Bavendam, T.4
  • 32
    • 14144255467 scopus 로고    scopus 로고
    • Validation of the Urgency Perception Scale
    • 10.1111/j.1464-410X.2005.05345.x 15705086
    • Cardozo L Coyne KS Versi E Validation of the Urgency Perception Scale BJU Int 2005, 95:591-596. 10.1111/j.1464-410X.2005.05345.x 15705086
    • (2005) BJU Int , vol.95 , pp. 591-596
    • Cardozo, L.1    Coyne, K.S.2    Versi, E.3
  • 33
    • 33746885531 scopus 로고    scopus 로고
    • Patient-reported outcomes in overactive bladder: The influence of perception of condition and expectation for treatment benefit
    • 10.1016/j.urology.2006.02.046
    • Marschall-Kehrel D Roberts RG Brubaker L Patient-reported outcomes in overactive bladder: The influence of perception of condition and expectation for treatment benefit Urology 2006, 68(suppl 2A):29-37. 10.1016/j.urology.2006.02.046
    • (2006) Urology , vol.68 , Issue.SUPPL. 2A , pp. 29-37
    • Marschall-Kehrel, D.1    Roberts, R.G.2    Brubaker, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.